Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerBilling CodesMalignant neuroendocrine tumorsICD-10-CM c7a-malignant-neuroendocrine-tumors
    Ask Trek AI about this page

    ICD-10-CM Code For Malignant Neuroendocrine Tumors: Group Overview

    The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code group C7A includes malignant neuroendocrine tumors, covering neoplasms of neuroendocrine cells that may arise in organs such as the pancreas, gastrointestinal tract, and respiratory system and that are characterized by malignant behavior. These ICD-10-CM diagnosis codes are used to document tumor site, malignant behavior, and any local or metastatic spread, capturing disease severity, organ involvement, or clinical complexity relevant to this group. Accurate coding within the ICD-10-CM C7A group supports proper claim adjudication, complete clinical documentation, and appropriate reimbursement.

    Customize your policy alerts

    Sign up for ICD-10-CM Code For Malignant Neuroendocrine Tumors: Group Overview policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    ICD-10-CM C7A: Malignant Neuroendocrine Tumors Overview

    The International Classification of Diseases, Tenth Revision, Clinical Modification code group C7A represents malignant neuroendocrine tumors arising in various sites where neuroendocrine cells are present. These neoplasms affect endocrine and neuroendocrine tissues and can involve multiple organ systems, including the gastrointestinal tract, pancreas, and lungs. Accurate coding matters for reimbursement because it ensures precise capture of tumor behavior, site, and extent, supporting appropriate claim adjudication and clinical documentation.

    Table of contents

    Progress1 / 6

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    When to Use

    Use a code from this group when a malignant neuroendocrine tumor has been clinically or pathologically diagnosed and the record specifies the site and malignant nature of the neoplasm. Codes from this group are appropriate for encounters that document initial diagnosis, ongoing management, treatment, or care related to the malignant neuroendocrine tumor and its complications.

    ICD-10-CM Codes

    23 rows

    ICD-10-CM CodeDescription
    C7A.00Malignant carcinoid tumor of unspecified site
    C7A.010Malignant carcinoid tumor of the duodenum
    C7A.011Malignant carcinoid tumor of the jejunum
    C7A.012Malignant carcinoid tumor of the ileum
    C7A.019Malignant carcinoid tumor of the small intestine, unspecified portion
    C7A.020Malignant carcinoid tumor of the appendix
    C7A.021Malignant carcinoid tumor of the cecum
    C7A.022Malignant carcinoid tumor of the ascending colon
    C7A.023Malignant carcinoid tumor of the transverse colon
    C7A.024Malignant carcinoid tumor of the descending colon
    C7A.025Malignant carcinoid tumor of the sigmoid colon
    C7A.026Malignant carcinoid tumor of the rectum
    C7A.029Malignant carcinoid tumor of the large intestine, unspecified portion
    C7A.090Malignant carcinoid tumor of the bronchus and lung
    C7A.091Malignant carcinoid tumor of the thymus
    C7A.092Malignant carcinoid tumor of the stomach
    C7A.093Malignant carcinoid tumor of the kidney
    C7A.094Malignant carcinoid tumor of the foregut, unspecified
    C7A.095Malignant carcinoid tumor of the midgut, unspecified
    C7A.096Malignant carcinoid tumor of the hindgut, unspecified

    Showing 1–20 of 23

    DRG Codes

    20 rows

    DRG CodeDescription
    180Respiratory Neoplasms with MCC
    181Respiratory Neoplasms with CC
    182Respiratory Neoplasms without CC/MCC
    374Digestive Malignancy with MCC
    375Digestive Malignancy with CC
    376Digestive Malignancy without CC/MCC
    656Kidney and Ureter Procedures for Neoplasm with MCC
    657Kidney and Ureter Procedures for Neoplasm with CC
    658Kidney and Ureter Procedures for Neoplasm without CC/MCC
    686Kidney and Urinary Tract Neoplasms with MCC
    687Kidney and Urinary Tract Neoplasms with CC
    688Kidney and Urinary Tract Neoplasms without CC/MCC
    826Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with MCC
    827Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with CC
    828Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures without CC/MCC
    829Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Other Procedures with CC/MCC
    830Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Other Procedures without CC/MCC
    843Other Myeloproliferative Disorders or Poorly Differentiated Neoplastic Diagnoses with MCC
    844Other Myeloproliferative Disorders or Poorly Differentiated Neoplastic Diagnoses with CC
    845Other Myeloproliferative Disorders or Poorly Differentiated Neoplastic Diagnoses without CC/MCC

    Typical Clinical Scenarios

    • A 62-year-old woman with months of intermittent flushing, diarrhea, and unexplained weight loss presents to oncology after imaging identifies a 4 cm mass in the mid-portion of the pancreas with biopsy showing well-differentiated neuroendocrine malignancy. She is referred for staging, treatment planning, and symptom management; a malignant pancreatic neuroendocrine tumor code is assigned to capture the primary site and malignant behavior. Typical codes: C7A.020, C7A.021
    • A 48-year-old man arrives at the emergency department with acute abdominal pain and melena; endoscopy reveals an actively bleeding small intestinal mass, and biopsy confirms a metastatic neuroendocrine carcinoma originating in the ileum. The acute presentation for hemorrhage and need for urgent intervention lead to assignment of the small intestine malignant neuroendocrine tumor code to document the primary malignant lesion. Typical codes: C7A.010, C7A.011, C7A.012
    • A 55-year-old patient with known metastatic neuroendocrine tumor of uncertain primary site is seen in follow-up for progressive carcinoid syndrome and new liver metastases confirmed on imaging. The visit documents ongoing malignant neuroendocrine disease as a chronic condition with metastatic complications, so a code reflecting malignant neuroendocrine tumor of the specified site or unspecified location is used to capture disease status and guide oncology care. Typical codes: C7A.098, C7A.1

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.